The global veterinary regenerative medicine market size is expected to reach USD 640.16 million by 2030. The market is expected to expand at a lucrative CAGR of 12.54% from 2023 to 2030. The key factors driving the growth include the rising incidence of soft tissue injuries and osteoarthritis in animals, rising pet industry expenditure, expanding access to veterinary services, and several advantages of animal stem cell therapy. Thirty-three percent of training losses and waste in sport horses across all categories are attributable to soft tissue injuries, which can damage any tendon or ligament. These injuries account for 13% to 18% of horses who need rest and time off. An increase in acute workload and fitness level, among other things, are two major factors that contribute to soft tissue injury in horses.
Animal stem cell therapy has several benefits, further fueling the market’s growth. These days, animal stem cell therapy is very popular due to its capacity to utilize an animal's own stem cells to prolong treatment for a disease or illness. Animals who receive this therapy live much longer. Many health problems, including arthritis, degenerative joint disorders, and ligament and tendon injuries in animals, have seen a large increase in occurrences in recent years. Cats, dogs, and horses are frequently treated with stem cell treatment. This factor is supporting the growth of the market for veterinary regenerative medicine worldwide.
Companies are focusing on animal stem cell therapies to reduce the prevalence of disease in animals and improve the animal's quality of life. Animal stem cell research has tremendous potential for understanding fundamental mechanisms of animal development, as well as for treating a wide range of diseases and disorders in animals. All of these factors work as drivers for the market for veterinary regenerative medicine to grow rapidly. Furthermore, increased investment in R&D activities in the animal stem cell therapy market is one of the primary factors driving the market growth.
Pet owners are reluctant to spend a sizable number of money on their pet's treatment because animal stem cell therapy is fairly expensive. Also, many conventional veterinary hospitals are not equipped to treat animals with stem cells. Although pet insurance companies pay for stem cell treatments, they do not pay for additional procedures like retreatment. A significant percentage of pet owners do not have pet insurance, which will limit the future growth of the market for animal regenerative medicine.
In veterinary medicine, regenerative therapies such as mesenchymal stem cells, platelet-rich plasma, and autologous serum products are becoming increasingly popular for treating horses and dogs. The main objectives of regenerative therapies are to control immune responses, stop the immune system from causing additional tissue damage, and administer trophic and growth hormones to promote endogenous tissue regeneration. The FDA has not yet approved any cell-based regenerative medicines.
A lack of standardization in the tissue origin, the timing of injection, dosing, and use of adjunct therapies may be the cause of the lack of agreement on treatment protocols for MSC therapy in veterinary medicine, which may account for variations in treatment efficacy reported for different clinical trials. For the treatment of tendinitis, osteoarthritis, and desmitis, MSC therapy has the most clinical evidence of clinical efficacy. When tendon injuries are treated with MSCs in horses and dogs, the tissue composition and fiber alignment are improved, and the recurrence rates are reduced.
Animal stem cell therapy has several benefits, further fueling the market’s growth. These days, animal stem cell therapy is very popular due to its capacity to utilize an animal's own stem cells to prolong treatment for a disease or illness. Animals who receive this therapy live much longer. Many health problems, including arthritis, degenerative joint disorders, and ligament and tendon injuries in animals, have seen a large increase in occurrences in recent years. Cats, dogs, and horses are frequently treated with stem cell treatment. This factor is supporting the growth of the market for veterinary regenerative medicine worldwide.
Companies are focusing on animal stem cell therapies to reduce the prevalence of disease in animals and improve the animal's quality of life. Animal stem cell research has tremendous potential for understanding fundamental mechanisms of animal development, as well as for treating a wide range of diseases and disorders in animals. All of these factors work as drivers for the market for veterinary regenerative medicine to grow rapidly. Furthermore, increased investment in R&D activities in the animal stem cell therapy market is one of the primary factors driving the market growth.
Pet owners are reluctant to spend a sizable number of money on their pet's treatment because animal stem cell therapy is fairly expensive. Also, many conventional veterinary hospitals are not equipped to treat animals with stem cells. Although pet insurance companies pay for stem cell treatments, they do not pay for additional procedures like retreatment. A significant percentage of pet owners do not have pet insurance, which will limit the future growth of the market for animal regenerative medicine.
In veterinary medicine, regenerative therapies such as mesenchymal stem cells, platelet-rich plasma, and autologous serum products are becoming increasingly popular for treating horses and dogs. The main objectives of regenerative therapies are to control immune responses, stop the immune system from causing additional tissue damage, and administer trophic and growth hormones to promote endogenous tissue regeneration. The FDA has not yet approved any cell-based regenerative medicines.
A lack of standardization in the tissue origin, the timing of injection, dosing, and use of adjunct therapies may be the cause of the lack of agreement on treatment protocols for MSC therapy in veterinary medicine, which may account for variations in treatment efficacy reported for different clinical trials. For the treatment of tendinitis, osteoarthritis, and desmitis, MSC therapy has the most clinical evidence of clinical efficacy. When tendon injuries are treated with MSCs in horses and dogs, the tissue composition and fiber alignment are improved, and the recurrence rates are reduced.
Veterinary Regenerative Medicine Market Report Highlights
- The stem cells segment is expected to grow for the highest revenue share over the forecast period
- Orthopedics dominated the market in 2022 with the largest revenue share of over 40.0% due to the increasing prevalence of arthritis in pets
- The small animals segment accounted for the highest revenue share in 2022. The increasing adoption of pets and increased costs for their well-being and health is expected to boost the market growth
- The veterinary hospitals & clinics segment accounted for the highest revenue share in 2022. In veterinary hospitals and clinics, the increased number of patients visiting these facilities for stem cell therapy and the growing number of veterinarians, which is projected to support segment growth
- North America is expected to dominate the veterinary regenerative medicine industry over the forecast period due to the increased awareness rate of the therapy
- Some of the key players are Boehringer Ingelheim International GmbH, Zoetis, Vetbiologics, and Animal Cell Therapies, Inc.
Table of Contents
Chapter 1 Research Methodology & Scope1.1 Market Segmentation & Scope
1.1.1 Estimates & Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Market Definition
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.2 Parent Market Analysis
1.8 List of Secondary Sources
1.9 Objectives
Chapter 2 Executive Summary
2.1 Market Snapshot, 2022 (USD Million)
2.2 Segment Snapshot
2.3 Competitive Snapshot
Chapter 3 Veterinary Regenerative Medicine Market: Market Variables Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.2.3 Market Opportunity Analysis
3.2.4 Market Challenge Analysis
3.3 Industry Analysis
3.3.1 Porter’s 5 Forces Analysis
3.3.1.1 Bargaining Power Of Buyers
3.3.1.2 Bargaining Power Of Suppliers
3.3.1.3 Threat Of New Entrants
3.3.1.4 Threat Of Substitutes
3.3.1.5 Industry Rivalry: High
3.3.2 Pestel Analysis
3.3.2.1 Political & Legal Landscape
3.3.2.2 Economic & Social Landscape
3.3.2.3 Environmental Landscape
3.3.2.4 Technology Landscape
3.4 Estimated Animal Population By Key Species & By Key Countries, 2018-2022
3.5 Regulatory Framework
3.6 Technology Trend Analysis
3.7 Pricing Analysis
3.8 Product Pipeline Analysis
3.9 Estimated Number Of Veterinarians By Key Countries/Region
3.10 Covid-19 Impact Analysis
Chapter 4 Veterinary Regenerative Medicine Market: Animal Type Analysis
4.1 Animal Type Market Share Analysis, 2022 & 2030
4.2 Veterinary Regenerative Medicine Market: Animal Type Movement Analysis, 2018 To 2030
4.3 Small Animals
4.3.1 Small Animals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4 Large Animals
4.4.1 Large Animals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5 Veterinary Regenerative Medicine Market: Product Analysis
5.1 Product Market Share Analysis, 2022 & 2030
5.2 Veterinary Regenerative Medicine Market: Product Movement Analysis, 2018 To 2030
5.3 Stem Cells
5.3.1 Stem Cells Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.4 Others
5.4.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 6 Veterinary Regenerative Medicine Market: Application Analysis
6.1 Application Market Share Analysis, 2022 & 2030
6.2 Veterinary Regenerative Medicine Market: Application Movement Analysis, 2018 To 2030
6.3 Orthopedics
6.3.1 Orthopedics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4 Trauma/Wound Care
6.4.1 Trauma/Wound Care Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5 Others
6.5.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7 Veterinary Regenerative Medicine Market: End-Use Analysis
7.1 End-Use Market Share Analysis, 2022 & 2030
7.2 Veterinary Regenerative Medicine Market: End-Use Movement Analysis, 2018 To 2030
7.3 Veterinary Hospitals/Clinics
7.3.1 Veterinary Hospitals/Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4 Veterinary Research Institutes
7.4.1 Veterinary Research Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8 Veterinary Regenerative Medicine Market: Regional Market Analysis, 2018 - 2030 (USD Million)
8.1 Regional Market Share Analysis, 2022 & 2030
8.2 Regional Market Snapshot
8.3 North America
8.3.1 Swot Analysis
8.3.1.1 North America Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.2 U.S.
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.3 U.S. Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.3 Canada
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.3 Canada Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4 Europe
8.4.1 Swot Analysis:
8.4.1.1 Europe Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.2 U.K.
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 U.K. Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3 Germany
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 Germany Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4 France
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 France Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.5 Italy
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Italy Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.6 Spain
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 Spain Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5 Asia Pacific
8.5.1 Swot Analysis:
8.5.1.1 Asia Pacific Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.2 Japan
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Japan Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3 China
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 China Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4 India
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 India Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.5 Australia
8.5.5.1 Key Country Dynamics
8.5.5.2 Competitive Scenario
8.5.5.3 Australia Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.6 South Korea
8.5.6.1 Key Country Dynamics
8.5.6.2 Competitive Scenario
8.5.6.3 South Korea Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6 Latin America
8.6.1 Swot Analysis:
8.6.1.1 Latin America Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.2 Brazil
8.6.2.1 Key Country Dynamics
8.6.2.2 Competitive Scenario
8.6.2.3 Brazil Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7 Mea
8.7.1 Swot Analysis:
8.7.1.1 Mea Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.2 South Africa
8.7.2.1 Key Country Dynamics
8.7.2.2 Competitive Scenario
8.7.2.3 South Africa Veterinary Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9 Veterinary Regenerative Medicine Market - Competitive Landscape
9.1 Key Company Profiles
9.1.1 Boehringer Ingelheim International Gmbh
9.1.2 Zoetis
9.1.3 Dechra
9.1.4 Acell Inc. (Integra Lifesciences)
9.1.5 Vetherapy
9.1.6 Vetstem, Inc.
9.1.7 Ardent
9.1.8 Enso Discoveries
9.1.9 Animal Cell Therapies, Inc.
9.1.10 Vetbiologics
9.1.11. Participant’s Overview
9.1.12. Financial Performance
9.1.13. Product Benchmarking
9.2. Participant Categorization
9.2.1. Market Leaders
9.2.2 Strategy Mapping
9.3. List Of Other Players
List of Tables
Table 1. List of secondary sources
Table 2. List of key companies
Table 3. Global Veterinary Regenerative Medicine market, by region, 2018 - 2030 (USD Million)
Table 4. Global Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 5. Global Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 6. Global Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 7. Global Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 8. North America Veterinary Regenerative Medicine market, by country, 2018 - 2030 (USD Million)
Table 9. North America Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 10. North America Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 11. North America Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 12. North America Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 13. U.S. Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 14. U.S. Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 15. U.S. Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 16. U.S. Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 17. Canada Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 18. Canada Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 19. Canada Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 20. Canada Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 21. Europe Veterinary Regenerative Medicine market, by country, 2018 - 2030 (USD Million)
Table 22. Europe Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 23. Europe Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 24. Europe Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 25. Europe Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 26. U.K. Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 27. U.K. Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 28. U.K. Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 29. U.K. Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 30. Germany Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 31. Germany Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 32. Germany Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 33. Germany Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 34. France Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 35. France Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 36. France Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 37. France Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 38. Italy Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 39. Italy Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 40. Italy Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 41. Italy Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 42. Spain Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 43. Spain Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 44. Spain Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 45. Spain Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 46. Asia Pacific Veterinary Regenerative Medicine market, by country, 2018 - 2030 (USD Million)
Table 47. Asia Pacific Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 48. Asia Pacific Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 49. Asia Pacific Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 50. Asia Pacific Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 51. China Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 52. China Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 53. China Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 54. China Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 55. Japan Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 56. Japan Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 57. Japan Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 58. Japan Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 59. India Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 60. India Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 61. India Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 62. India Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 63. Australia Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 64. Australia Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 65. Australia Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 66. Australia Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 67. South Korea Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 68. South Korea Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 69. South Korea Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 70. South Korea Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 71. LATAM Veterinary Regenerative Medicine market, by country, 2018 - 2030 (USD Million)
Table 72. LATAM Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 73. LATAM Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 74. LATAM Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 75. LATAM Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 76. Brazil Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 77. Brazil Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 78. Brazil Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 79. Brazil Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 80. MEA Veterinary Regenerative Medicine market, by country, 2018 - 2030 (USD Million)
Table 81. MEA Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 82. MEA Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 83. MEA Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 84. MEA Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
Table 85. South Africa Veterinary Regenerative Medicine market, by animal type, 2018 - 2030 (USD Million)
Table 86. South Africa Veterinary Regenerative Medicine market, by Product, 2018 - 2030 (USD Million)
Table 87. South Africa Veterinary Regenerative Medicine market, by Application, 2018 - 2030 (USD Million)
Table 88. South Africa Veterinary Regenerative Medicine market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Parent Market Analysis
Fig. 10 Commodity flow analysis
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Competitive landscape snapshot
Fig. 14 Veterinary Regenerative Medicine Market Dynamics
Fig. 15 Veterinary Regenerative Medicine Market: PORTER’s Analysis
Fig. 16 Veterinary Regenerative Medicine Market PESTLE Analysis
Fig. 17 Veterinary Regenerative Medicine market Animal type outlook: Key takeaways, 2022 & 2030
Fig. 18 Veterinary Regenerative Medicine market: Animal type movement analysis
Fig. 19 Global small animals market 2018 - 2030 (USD Million)
Fig. 20 Global large animals market 2018 - 2030 (USD Million)
Fig. 21 Veterinary Regenerative Medicine market product outlook: Key takeaways, 2022 & 2030
Fig. 22 Veterinary Regenerative Medicine market: Product movement analysis
Fig. 23 Global stem cells market 2018 - 2030 (USD Million)
Fig. 24 Global others market 2018 - 2030 (USD Million)
Fig. 25 Veterinary Regenerative Medicine market Application outlook: Key takeaways, 2022 & 2030
Fig. 26 Veterinary Regenerative Medicine market: Application movement analysis
Fig. 27 Global orthopedics market 2018 - 2030 (USD Million)
Fig. 28 Global trauma/wound care market 2018 - 2030 (USD Million)
Fig. 29 Global others market 2018 - 2030 (USD Million)
Fig. 30 Veterinary Regenerative Medicine market End-Use outlook: Key takeaways, 2022 & 2030
Fig. 31 Veterinary Regenerative Medicine market: End-use movement analysis
Fig. 32 Global veterinary hospitals/clinics market 2018 - 2030 (USD Million)
Fig. 33 Global veterinary research institutes market 2018 - 2030 (USD Million)
Fig. 34 Regional outlook, 2022 & 2030
Fig. 35 Regional marketplace: Key takeaways
Fig. 36 North America Veterinary Regenerative Medicine market by countries, 2018 - 2030 (USD Million)
Fig. 37 U.S. Veterinary Regenerative Medicine market, 2018 - 2030 (USD Million)
Fig. 38 Canada Veterinary Regenerative Medicine market, 2018 - 2030 (USD Million)
Fig. 39 Europe Veterinary Regenerative Medicine market by countries, 2018 - 2030 (USD Million)
Fig. 40 U.K. Veterinary Regenerative Medicine market, 2018 - 2030 (USD Million)
Fig. 41 Germany Veterinary Regenerative Medicine market, 2018 - 2030 (USD Million)
Fig. 42 France Veterinary Regenerative Medicine market, 2018 - 2030 (USD Million)
Fig. 43 Italy Veterinary Regenerative Medicine market, 2018 - 2030 (USD Million)
Fig. 44 Spain Veterinary Regenerative Medicine market, 2018 - 2030 (USD Million)
Fig. 45 Asia Pacific Veterinary Regenerative Medicine market by countries, 2018 - 2030 (USD Million)
Fig. 46 China Veterinary Regenerative Medicine market, 2018 - 2030 (USD Million)
Fig. 47 Japan Veterinary Regenerative Medicine market, 2018 - 2030 (USD Million)
Fig. 48 India Veterinary Regenerative Medicine market, 2018 - 2030 (USD Million)
Fig. 49 Australia Veterinary Regenerative Medicine market, 2018 - 2030 (USD Million)
Fig. 50 South Korea Veterinary Regenerative Medicine market, 2018 - 2030 (USD Million)
Fig. 51 Latin America Veterinary Regenerative Medicine market by countries, 2018 - 2030 (USD Million)
Fig. 52 Brazil Veterinary Regenerative Medicine market, 2018 - 2030 (USD Million)
Fig. 53 MEA Veterinary Regenerative Medicine market by countries, 2018 - 2030 (USD Million)
Fig. 54 South Africa Veterinary Regenerative Medicine market, 2018 - 2030 (USD Million)
Fig. 55 Market participant categorization
Fig. 56 Company market position analysis
Companies Mentioned
- Boehringer Ingelheim International Gmbh
- Zoetis
- Dechra
- Acell Inc. (Integra Lifesciences)
- Vetherapy
- Vetstem, Inc.
- Ardent
- Enso Discoveries
- Animal Cell Therapies, Inc.
- Vetbiologics
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | March 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 257.54 Million |
| Forecasted Market Value ( USD | $ 640.16 Million |
| Compound Annual Growth Rate | 12.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
